Hiroyasu Aoki
Impact in
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Immunology 16
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 4
- Oncology 8
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- MASAKUNI OKUHARA (2 shared papers)Satoshi Ueha (11 shared papers)Shigeyuki Shichino (10 shared papers)Kouji Matsushima (10 shared papers)MASANOBU KOHSAKA (2 shared papers)Takenori Ochiai (1 shared paper)Kunio Nakahara (1 shared paper)Tetsuhisa Goto (1 shared paper)
- Journals
- Infection and Immunity (3 papers)Frontiers in Immunology (3 papers)Cancer Immunology Research (3 papers)The Journal of Immunology (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- JapanUnited KingdomNew Zealand
In The Last Decade
Hiroyasu Aoki
22 papers receiving 272 citations
Peers
Comparison fields: 5 of 71
- Immunology 136
- Transplantation 17
- Oncology 83
- Molecular Medicine 10
- Pharmacology 34
Countries citing papers authored by Hiroyasu Aoki
This map shows the geographic impact of Hiroyasu Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyasu Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyasu Aoki more than expected).
Fields of papers citing papers by Hiroyasu Aoki
This network shows the impact of papers produced by Hiroyasu Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyasu Aoki. The network helps show where Hiroyasu Aoki may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroyasu Aoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of FK-506 on human mixed lymphocyte reaction in vitro. | 1987 | 55 |
| 2 | 2022 | 27 | |
| 3 | 2021 | 24 | |
| 4 | 2019 | 23 | |
| 5 | 1980 | 23 | |
| 6 | 2022 | 21 | |
| 7 | 1972 | 21 | |
| 8 | 1984 | 17 | |
| 9 | 2021 | 13 | |
| 10 | 1981 | 12 | |
| 11 | Screening of new and novel beta-lactam antibiotics. | 1977 | 11 |
| 12 | 1985 | 8 | |
| 13 | 1980 | 7 | |
| 14 | 2024 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 3 | |
| 18 | 1994 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 2 |
About Hiroyasu Aoki
Hiroyasu Aoki is a scholar working on Immunology, Oncology, Molecular Biology, Pharmacology and Infectious Diseases, having authored 23 papers that have together received 293 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), T-cell and B-cell Immunology (4 papers), Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (4 papers), Animal Virus Infections Studies (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Immunology (136 citations), Transplantation (17 citations), Oncology (83 citations), Molecular Medicine (10 citations) and Pharmacology (34 citations). Hiroyasu Aoki has collaborated with scholars based in Japan, United Kingdom and New Zealand. Frequent co-authors include MASAKUNI OKUHARA, Satoshi Ueha, Shigeyuki Shichino, Kouji Matsushima, MASANOBU KOHSAKA, Takenori Ochiai, Kunio Nakahara, Tetsuhisa Goto, TOHRU KINO and Noriaki Inamura. Their work appears in journals such as Infection and Immunity, Frontiers in Immunology, Cancer Immunology Research, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.